ResMed Inc. (ASX:RMD)

ResMed Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 28, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	53,705	57,599	42,141	48,280	44,545	47,888
Market Cap Growth	-2.28%	36.68%	-12.72%	8.38%	-6.98%	19.03%
Enterprise Value	52,936	57,438	43,502	50,510	45,434	48,707
Last Close Price	36.40	39.17	28.71	32.03	29.20	30.97
PE Ratio	24.70	26.96	27.54	35.80	39.38	75.67
PS Ratio	6.76	7.34	6.00	7.61	8.58	11.23
PB Ratio	5.80	6.33	5.78	7.78	9.13	12.44
P/TBV Ratio	13.51	15.37	18.30	39.81	28.46	63.52
P/FCF Ratio	20.09	22.73	21.60	56.02	141.88	56.63
P/OCF Ratio	18.86	21.56	20.07	46.35	87.40	48.73
EV/Sales Ratio	7.04	7.32	6.20	7.96	8.75	11.42
EV/EBITDA Ratio	18.68	20.24	18.93	26.02	27.80	35.49
EV/EBIT Ratio	20.95	22.32	20.97	29.18	31.24	39.80
EV/FCF Ratio	19.80	22.66	22.30	58.60	144.71	57.60
Debt / Equity Ratio	0.14	0.14	0.18	0.38	0.27	0.28
Debt / EBITDA Ratio	0.43	0.45	0.56	1.19	0.79	0.75
Debt / FCF Ratio	0.48	0.51	0.67	2.75	4.24	1.25
Asset Turnover	0.68	0.68	0.69	0.71	0.73	0.69
Inventory Turnover	2.03	2.09	1.87	1.84	2.30	2.97
Quick Ratio	1.87	2.16	1.22	1.23	1.28	1.01
Current Ratio	2.89	3.44	2.59	3.12	2.80	1.73
Return on Equity (ROE)	25.41%	25.86%	22.70%	23.96%	24.96%	17.63%
Return on Assets (ROA)	14.19%	14.02%	12.70%	12.15%	12.75%	12.31%
Return on Invested Capital (ROIC)	26.01%	25.36%	20.35%	19.81%	22.04%	14.67%
Return on Capital Employed (ROCE)	25.00%	23.60%	23.20%	19.20%	22.70%	24.00%
Earnings Yield	4.05%	3.71%	3.63%	2.79%	2.54%	1.32%
FCF Yield	4.98%	4.40%	4.63%	1.79%	0.70%	1.77%
Dividend Yield	0.93%	8.25%	10.02%	8.26%	8.35%	6.85%
Payout Ratio	2.29%	22.19%	27.65%	28.78%	31.48%	47.78%
Buyback Yield / Dilution	0.28%	0.14%	-0.06%	-0.28%	-0.40%	-0.55%
Total Shareholder Return	1.21%	8.40%	9.96%	7.98%	7.95%	6.30%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.